By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Destiny Pharma Ltd. 

Sussex Innovation Centre
Science Park Square
Falmer  Brighton  BN1 9SB  United Kingdom
Phone: 44-0-1273-704440 Fax: n/a


SEARCH JOBS

Destiny Pharma, a leading, clinical stage biopharmaceutical company, founded in 1997. The Company focuses on the R&D of new antimicrobial drugs, with an emphasis on novel mechanisms of action that seek to address the global healthcare issue, namely, Antibiotic Resistance. Exeporfinium chloride is the Company's lead drug which has completed 3 Phase I/IIa clinical studies in the UK/Europe. Through its extensive business network and strategic partnerships, Destiny Pharma intends to globally commercialize candidates from the XF Drug platform based on dicationic porphyrins which are differentiated from traditional antibiotics structurally. XF drug candidates are able to kill static and growing bacterial cultures, as well as bacteria with biofilm and may thus see limited resistance development. Non-growing cultures often become resistant to traditional antibiotics that rely on the bacteria actively growing to kill them.

YEAR FOUNDED:

1997

LEADERSHIP:

Founder and CEO: Bill Love

FOLLOW DESTINY PHARMA:




Key Statistics


Email: info@destinypharma.com
Ownership: Private

Web Site: Destiny Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->